Millennium Management
NUVB icon

Millennium Management’s Nuvation Bio NUVB Stock Holding History

Millennium Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,600
Closed -$34.3K – 6389
2023
Q3 		$34.3K Buy
+25,600
New +$42.6K ﹤0.01% 5554

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's NUVB Position: Q1 2026 in Review

Millennium Management increased its Nuvation Bio (NUVB) stake by 58% in Q1 2026, buying an estimated $2.29M and bringing the position to 1,122,180 shares worth $4.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2989.

Millennium Management first reported a position in NUVB in Q3 2020 and has held it in 20 quarters since. The position peaked at $18M in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Millennium Management held 1,122,180 shares of Nuvation Bio worth $4.81M as of Q1 2026.
  • Millennium Management bought 410,636 Nuvation Bio shares in Q1 2026, an estimated $2.29M.
  • Nuvation Bio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2989 holding.
  • Millennium Management first reported a position in Nuvation Bio in Q3 2020 and has held it in 20 quarters since.
  • Millennium Management's Nuvation Bio position peaked at $18M in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.